We have updated our Online Services Terms of Use and Privacy Policy. See our Cookies Notice for information concerning our use of cookies and similar technologies. By using this website or clicking “I ACCEPT”, you consent to our Online Services Terms of Use.

Schedule an appointment today

Find University Hospitals Doctors

Mark Cohen, MD

Mark Cohen, MD



Not Accepting New Patients

Primary Location

Case Western Reserve University
2085 Adelbert Rd
Cleveland, OH 44106

Schedule an Appointment



  • Professor, CWRU School of Medicine

After graduating from Cornell University College of Arts and Sciences and Medical School, Dr. Cohen became board-certified in Anatomic, Clinical, and Neuropathology at University Hospitals of Cleveland, where he is now Professor of Pathology and Neurology as well as Co-Director of the National Prion Disease Pathology Surveillance Center.


  • Diagnostic Neuropathology
  • Gastrointestinal Pathology
  • Neurodegenerative Diseases
  • Prion Diseases

Languages Spoken


Office Locations

Case Western Reserve University

2085 Adelbert Rd
Cleveland, OH 44106

Research & Publications

Research Interests

Prion disease, Neuromuscular pathology

Certifications & Memberships

  • Neuropathology - American Board of Pathology
  • Anatomic and Clinical Pathology - American Board of Pathology


Fellowship | Neuropathology
Neuropathology - University Hospitals Of Cleveland (1988 - 1990)

Residency | Anatomic and Clinical Pathology
Anatomic and Clinical Pathology - University Hospitals Of Cleveland (1984 - 1988)

Internship | Internal Medicine
Internal Medicine - University Hospitals Of Cleveland (1983 - 1984)

Medical Education
Weill Cornell Medical College (1983)

Cornell University (1979)

Industry Relationships

University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.

UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.

View UH’s policy (PDF) on practitioner-industry relationships.

As of December 31, 2016, Mark Cohen did not disclose any Outside Relationships with Industry.